In vivo anti-inflammatory activity of lipoic acid derivatives in mice

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 331-338

  Kwiecień, Brunon ^a   Dudek, Magdalena ^b   Bilska Wilkosz, Anna ^b   Knutelska, Joanna ^b   Bednarski, Marek ^b   Kwiecień, Inga ^b   Zygmunt, Małgorzata ^b   Iciek, Małgorzata ^b   Sokołowska Jezewicz, Maria ^b   Sapa, Jacek ^b   Włodek, Lidia ^b  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

2,4 (bismethylthio) butanoic acid; Anti inflammatory properties; Carrageenan; Dihydrolipoic acid; Hydrogen sulfide; Lipoic acid; Tetranor dihydrolipoic acid; Zymosan

Indexed keywords

2,4 BISMETHYLTHIOBUTANOIC ACID; 2,4-BISMETHYLTHIOBUTANOIC ACID; ANTIINFLAMMATORY AGENT; BUTYRIC ACID DERIVATIVE; CARRAGEENAN; DRUG DERIVATIVE; TETRANOR DIHYDROLIPOIC ACID; TETRANOR-DIHYDROLIPOIC ACID; THIOCTIC ACID; THIOL DERIVATIVE; ZYMOSAN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EDEMA; INTRAPERITONEAL DRUG ADMINISTRATION; LD 50; MALE; MOUSE; PERITONITIS; TOXICITY TESTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BUTYRATES; CARRAGEENAN; EDEMA; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MALE; MICE; PERITONITIS; SULFHYDRYL COMPOUNDS; THIOCTIC ACID; TOXICITY TESTS, ACUTE; ZYMOSAN;

EID: 84883619301     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1046290     Document Type: Article

References (35)

1. Biewenga G. P., Haenen G. R., Bast A.: The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol., 1997;29:315-331
2. Bilska A., Włodek L.: Lipoic acid - the drug of the future? Pharmacol. Rep., 2005;57:570-577
3. Choi Y. H., Chai O. H., Han E. H, Choi S. Y., Kim H. T., Song C. H.: Lipoic acid suppresses compound 48/80-induced anaphylaxis-like reaction. Anat. Cell Biol., 2010;43:317-324
4. De la Fuente M., Miquel J.: An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr. Pharm. Des., 2009;15:3003-3026
5. Ekundi-Valentim E., Santos K. T., Camargo E. A., Denadai-Souza A., Teixeira S. A., Zanoni C. I., Grant A. D., Wallace J., Muscará M. N., Costa S. K.: Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br. J. Pharmacol., 2010;159:1463-1474
6. Fiorucci S., Mencarelli A., Caliendo G., Santagada V., Distrutti E., Santucci L., Cirino G., Wallace J. L.: Enhanced activity of a hydrogen-sulfide releasing mesalamine derivative (ATB-429) in a mouse model of colitis. Br. J. Pharmacol., 2007;150:996-1002
7. Gora̧ca A., Huk-Kolega H., Piechota A., Kleniewska P., Ciejka E., Skibska B.: Lipoic acid - biological activity and therapeutic potential. Pharmacol. Rep., 2011;63:849-858
8. Hsu C. C., Yen H. F., Yin M. C., Tsai C. M., Hsieh C. H.: Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J. Nutr., 2004;134:3245-3249
9. Jesudason E. P., Masilamoni J. G., Jebaraj C. E., Paul S. F., Jayakumar R.: Efficacy of DL-α lipoic acid against systemic inflammation-induced mice: antioxidant defense system. Mol. Cell Biochem., 2008;313:113-123
10. Kołaczkowska E., Barteczko M., Plytycz B., Arnold B.: Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflamm. Res., 2008;57:272-278
11. Konrad D.: Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation? Antioxid Redox Signal., 2005;7:1032-1039
12. Ley K., Deem T. L.: Oxidative modification of leukocyte adhesion. Immunity, 2005;22:5-7
13. Litchfield T., Wilcoxon F.: A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 1949;96:99-113
14. Livack J. E., Britton E. C., Vander Weele J. C., Murray M. F.: Synthesis of dl-Methionine. J. Am. Chem. Soc., 1945;67:2218-2220
15. Malińska D., Winiarska K.: Lipoic acid: Characteristics and therapeutic application. Postȩpy Hig. Med. Dośw., 2005;59:535-543
16. Mikami Y., Shibuya N., Kimura Y., Nagahara N., Ogasawara Y., Kimura H.: Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem. J., 2011;439:479-485
17. Odabasoglu F., Halici Z., Aygun H., Halici M., Atala F., Cakir A., Cadirci E., Bayir Y., Suleyman H.: α-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br. J. Nutr., 2011;105:31-43
18. Packer L., Witt E. H., Tritschler H. J.: α-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 1995;19:227-250
19. Plieninger H.: Die Aufspaltung des γ-Butyrolactons und α-Amino-γ-butyrolactons mit Natriummethylmercaptid bzw.-selenid. Eine Synthese des Methionins. Chem. Ber., 1950;83:265-268
20. Reed L. J., Niu C. I.: Syntheses of DL-α-Lipoic acid. J. Am. Chem. Soc., 1955;77:416-419
21. Schupke H., Hempel R., Peter G., Hermann R., Wessel K., Engel J., Kronbach T.: New metabolic pathways of alpha-lipoic acid. Drug. Metab. Dispos., 2001;29:855-862
22. Skibska B., Józefowicz-Okonkwo G., Gora̧ca A.: Protective effects of early administration of alpha-lipoic acid against lipopolysaccharide induced plasma lipid peroxidation. Pharmacol. Rep., 2006;58:399-404
23. Smith A. R., Shenvi S. V., Widlansky M., Suh J. H., Hagen, T. M.: Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem., 2004;11:1135-1146
24. Szela̧g M., Mikulski D., Molski M.: Quantum-chemical investigation of the structure and the antioxidant properties of α-lipoic acid and its metabolites. J. Mol. Model., 2012;18:2907-2916
25. Teichert J., Hermann R., Ruus P., Preiss R.: Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J. Clin. Pharmacol., 2003;43:1257-1267
26. Villarejo M., Westley J.: Mechanism of rhodanese catalysis of thiosulfate-lipoate oxidation-reduction. J. Biol. Chem., 1963;238:4016-4020
27. Wallace J. L., Ferraz J. G,. Muscara M. N.: Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid. Redox. Signal., 2012;17:58-67
28. Winter C. A., Risley E. A., Nuss G. W.: Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 1962;111:544-547
29. Wollin S. D., Jones P. J.: Alpha-lipoic acid and cardiovascular disease. J. Nutr., 2003;133:3327-3330
30. Xu Z. S., Wang X. Y., Xiao D. M., Hu L. F., Lu M., Wu Z. Y,. Bian J. S.: Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic. Biol. Med., 2011;50:1314-1323
31. Yazawa K., Suga K., Homma A., Shirosaki M., Koyama T.: Anti-inflammatory effects of seeds of the tropical fruit Camu-Camu (Myrciaria dubia). J. Nutr. Sci. Vitaminol., 2011;57:104-107
32. Yin M. C., Hsu C. C., Chiang P. F., Wu W. J.: Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice. Mol. Nutr. Food Res., 2007;51:572-579
33. Zanardo R. C., Brancaleone V., Distrutti E., Fiorucci S., Cirino G., Wallace J. L.: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J., 2006;20:2118-2120
34. Zhang W. J., Wei H., Hagen T., Frei B.: Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl. Acad. Sci. USA, 2007;104:4077-4082
35. Ziegler D.: Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat. Endocrinol., 2004;3:173-189